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local RAEC delivery prevented AAA formation (diameter increase at D0+7: 
22±2 vs 35±3% and D0+28: 49±6 vs 81±6% in RAEC and control rats, res-
pectively, both p<0.05) and stabilized already-formed AAA (diameter increase 
at D14+7: 1±3 vs 13±4% and D14+28: 0±4 vs 28±12%, p<0.05). This effect 
was associated with a decrease in proteolysis and inÀ ammation, the forma-
tion of VSMC and ECM-rich new luminal wall, and the formation of a new 
endothelial layer. Furthermore, transplanted cells did not directly participate to 
the aortic reconstruction but exerted healing properties mainly through para-
crine mechanisms, involving up regulation of stabilizing factors such as bFGF, 
eNOS, and the recruitment of bone marrow-derived progenitor cells.
Conclusion: Endovascular cell therapy using mature endothelial cells 
prevents development and expansion of AAA in rats, by re-establishing the 
endothelial lining and reconstructing a new aortic wall through paracrine 
mechanisms.
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Heart failure is a progressive disorder initiated by a loss of functional car-
diomyocytes leading to the weakening of the pumping capacity of the heart. In 
this context, cell replacement therapies to induce myocardial regeneration repre-
sent attractive alternatives to classical drug approaches for maintaining cardiac 
function. In a ¿ rst study, we isolated cardiac precursor cells (CPCs) from human 
fetal ventricles. These mesenchymal cells can proliferate in vitro and express 
early cardiac markers (Nkx2.5 and Gata4) but no cardiac proteins expressed 
in functional cardiomyocytes, such as contractile proteins of the sarcomere. In 
appropriate conditions, these cells can differentiate into functional cardiomyo-
cytes and smooth muscle cells (SMC). In order to identify a suitable source 
of cardiomyocyte precursors that could be used in autologous cell replacement 
therapy in humans, we established the conditions to isolate a mesenchymal non-
myocyte fraction from human adult atrial appendages. Minced tissue was sub-
jected to enzymatic digestion and the non-myocyte fraction was isolated and 
expanded in vitro. Flow cytometry analysis of cells in expansion showed no 
expression of hematopoietic markers (c-kit and CD45) and low or no expres-
sion of the endothelial stem cell markers CD34 (<10%) and CD31 (0%). In 
contrast, 100% of the cells expressed the mesenchymal stem cell markers CD73, 
CD90 and CD105. Cells under expansion conditions expressed early cardiac 
markers such as Mef2c, GATA4, and Nkx2.5 but no contractile proteins of the 
sarcomere and no SMC markers. This pattern of expression is consistent with a 
CPCs phenotype. Induction of differentiation in vitro stimulated the expression 
of ß-MHC and sm-MHC in CPCs. We are currently establishing a model ena-
bling assessment of the CPCs’ potential for engraftment and differentiation in 
the rodent myocardium. In this model, the cells were injected in the temporal 
vein of 2-days old SCID mice and are able to home back to the heart, to engraft 
and to differentiate into cardiomyocytes. Taken together, these data demonstrate 
that we successfully isolated mesenchymal CPCs from human atrial appendages. 
These cells are able to proliferate and differentiate into cardiomyocytes in vitro 
and in vivo, and might, therefore, represent a suitable source of precursors for 
autologous cell replacement therapy.
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Background: Increased risk of cardiovascular disease in patients with 
chronic renal failure (CRF) has been partly explained by accelerated impaired 
angiogenesis in which endothelial cells may play key role. Uremic solutes 
retained in these patients could be involved in endothelial dysfunction, but 
underlying mechanisms are poorly understood. We hypothesized that inor-
ganic phosphate (Pi) is an important representative of the uremic toxins that 
could be associated with impaired angiogenesis involved in cardiovascular 
complications and peripheral ischemic observed in CRF patients. The objec-
tive of this study is to determine if Pi is a potential inhibitor of endothelial 
cell proliferation.
Methods and results: We tested the Pi effects at concentrations of 1mM 
(normal concentration), 2mM (uremic concentration) and 3mM (maximal 
uremic concentration) on (i) Human Umbilical Endothelial Cells (HUVEC) 
viability and proliferation, (ii) cell cycle FACS analysis and (iii) on the cell 
cycle regulatory protein expression. Cell proliferation assay, shows that at 
2mM and 3mM, Pi reduces endothelial cell viability respectively by 29% 
(p<0.01) and 39% (p<0.001) vs control (Pi 1mM) and proliferation respecti-
vely by 33% (p<0.001) and 45% (p<0.001)vs control (Pi 1mM). Flow cyto-
metry analysis shows that at both 2mM and 3mM, Pi blocks the cell cycle in 
G1/S transition phase. Western blotting analysis shows that, Pi increased P27 
expression which is the cell cycle inhibitor of Cyclin/Cdk2 in G1/S transition.
Conclusion: In this study, we show that Pi that is one of the major uremic 
toxins strongly implicated in cardiovascular diseases, at both 2mM and 3mM 
concentrations inhibits endothelial cell proliferation, essential step in the 
angiogenic process. This inhibition involved blocking the cell cycle in G1/S 
by increasing P27 activity. Pi may be one of the strongest risk factor for angio-
genesis dysfunction in CRF patients.  
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Background: Abdominal aortic aneurysms (AAAs) result from extracellular 
matrix (ECM) destruction and vascular smooth muscle cells (VSMC) deple-
tion. Loss of endothelium and presence of mural thrombus is also common in 
human AAA. Since endothelium exerts anti-thrombotic properties and since the 
thrombus participates in AAA expansion, we hypothesized that restoration of a 
functional endothelium by cell therapy would stabilize AAA. We thus studied 
the impact of endothelial cells seeding on AAA evolution in rats.
Methods and results: Rat aortic endothelial cells (RAEC) cultures were 
established from male Fischer rat aorta. Their effect on AAA formation was 
evaluated in the xenograft model. 5.106 RAEC (n=16) or 200l of vehicle 
(control, n=14) were seeded endovascularly either immediately (D0, preven-
tion) or 14 days (D14, stabilization) after surgery, i.e., on already-formed 
AAA. Animals were sacri¿ ced 7 (prevention: D0+7; stabilization: D14+7) or 
28 (prevention: D0+28; stabilization: D14+28) days after seeding. In vivo, 
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Current approaches for creating bio-arti¿ cial pacemakers are based on gene 
or cell therapy approaches. In this study we attempted to develop a new stra-
tegy for generating cardiac bio-arti¿ cial pacemakers by overexpressing T-box 
transcription factor 3 (Tbx3). Tbx3 regulates sinus node (SAN) pacemaker 
gene expression program and phenotype during cardiac development. Ectopic 
expression of Tbx3 in mouse was shown to repress the atrial phenotype and 
impose the pacemaker phenotype on the atria. We hypothesized that Tbx3 
could reprogram working ventricular myocytes in giving them a phenotype 
similar to SAN pacemaker cells.
Neonatal mouse (1-2 days old) ventricular myocytes were transduced with 
Tbx3 gene with an adenovirus vector (Ad-tbx3) 24 hours after isolation. Non 
coding adenovirus (Ad-Null) was used for control myocytes. Real-time PCR 
and Western blots were used to investigate the expression of genes encoding 
ion channel subunits 24 and 48h post infection.
We observed at 24 h and 48 h after infection that expression levels of 
working myocardium-enriched genes encoding Nav1.5 cardiac Na+ channel 
and connexin (Cx) 43, which is typical of fast-conducting working myocar-
dium were down regulated (by 0.42 and 0.38 times, respectively; p<0.01, 
p<0.001) in Ad-tbx3 cells versus Ad-Null cells. In constrast, Ad-Tbx3 cells 
exhibited an upregulation of expression levels of SAN-enriched genes like 
Hcn4, which codes a pacemaker f channel (by 2 times; p<0.01), Cacna1d and 
Cacna1g, which encode the L-type Cav1.3 (1.72 times; p<0.001) and T-type 
Cav3.1 (1.40 times; p<0.01) Ca2+ channels and Gjc3 (by 2.72 times; p<0.001) 
encoding the connexin 30.2 which contributes to slow conduction velocity in 
the SAN. These results were con¿ rmed at protein levels.
Our study suggests the possibility that overexpression of Tbx3 in ventri-
cular myocytes may create pacemaker cells in vitro. Then, it will be inte-
resting to examine whether Tbx3 could generate bio-arti¿ cial ventricular 
pacemakers in vivo.
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Mobilization of bone marrow (BM) derived progenitor cells plays a major 
role in postischemic tissue remodeling. Catecholamines have been shown to 
control BM-derived cells egress from BM to blood and subsequently may 
affect post-ischemic vessel growth.
In mice with right femoral artery ligation, BM tyrosine hydroxylase 
mRNA levels were increased by 1400%, 24 hours after ischemia, sugges-
ting an increase in BM synthesis of dopamine (DA) and norepinephrin (NE). 
Angiographic score, capillary density and arteriole number were increased 
by around 40% (p<0.001), 25% (p<0.01), and 27% (p<0.01), respecti-
vely after 21 days of treatment with DA (i.p. 50mg/kg, 5 days) or NE (i.p. 
2.5mg/kg, 5 days). Using chimeric mice lethally irradiated and transplanted 
with BM-derived cells (BMC) from GFP mice, we showed that DA and NE 
enhanced by 70%(p<0.01) and 62% (p<0.001), respectively the number of 
GFP-positive BMC in ischemic tissue, and promoted their ability to differen-
tiate into cells with endothelial and inÀ ammatory phenotypes. Similarly, both 
DA and NE increased the in vitro differentiation of cultured BMC into cells 
with endothelial phenotype. This increase was blunted by nitric oxide synthase 
inhibitor, L-NAME. DA and NE also upregulated the number of CD45-positive 
cells in blood, 3 days after ischemia and that of macrophages in ischemic 
tissue 21 days after ischemia. DA and NE increased BM eNOS mRNA levels 
and were unable to promote BMC mobilization in chimeric eNOS-de¿ cient 
mice lethally irradiated and transplanted with BMC from wild-type animals. 
Furthermore, administration of a beta(2) adrenergic agonist (clenbuterol, i.p. 
The differentiation function and paracrine action of mesenchymal stem 
cells (MSCs) have been widely reported, allowing improvement in cardiac 
function of ischemic heart in animal models. However, progress in stem cell 
therapy is hampered by the poor survival of implanted cells in ischemic 
tissue.
Objective: To investigate echocardiography and histological effects of 
hypoxic preconditioning MSCs (Hy-MSCs) implantation in a pig chronic 
ischemic heart.
Methods: Ameroid constrictor was placed around the circumÀ ex artery in 
27 male pigs. Then, either Hy-MSCs or MSCs (1.106 cells/kg) were injected 
in the ischemic infero-lateral area after 1 month follow up. Control subgroup 
(PLB) was assessed injecting physiologic serum (20 ml). After 1 and 2 month 
follow-up echocardiography was performed allowing left ventricular ejection 
fraction (LVEF), diastolic function (E/e’ ratio) and peak infero-lateral two-
dimensional longitudinal strain (ILS) imaging. Immunohistochemical analysis 
was also performed for capillary and MSCs detection.
Results: After 1 month follow-up, LVEF, E/e’ and ILS were degraded 
from 61±5% to 51±9% (p=0.008), 6.7±1 to 7.7±1 (p=0.17) and -19%±2% to 
-13±3% (p<0.001). After 2 month follow-up, neither LVEF, E/e’ and ILS were 
signi¿ cantly improved in PLB (n=4) and MSC group (n=8). In Hy-MSC group 
(n=6) LVEF was increased from 50±8% to 58±5% and ILS was decreased 
from -15±1% to -19±1% (p<0.05). E/e’ was improved from 7.7±2 to 5.8±1 
(p=0.05). In addition, capillary density was higher in the Hy-MSC group than 
in the MSC and PLB group (2408±671/mm², 1636±801/mm² and 1279/mm²; 
p<0.001). MSCs density was higher in the Hy-MSC group (62±111/mm² and 
30±50/mm²; p=0.04).
Conclusion: MSCs engraftement after hypoxic preconditioning signi¿ -
cantly improves capillary density and MSCs survival after 1 month follow-
up, resulting in improvement in left ventricular function. This highlights the 
potential alternative therapeutic strategy in chronic ischemic heart failure.
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Ef¿ cacy of mesenchymal stem cell (MSC) myocardial transplantation 
after acute myocardial infarction (AMI) is limited by low MSC retention 
and survival after transplantation within the ischemic tissue. We hypothe-
sized that the injection of MSCs within a biomaterial would improve ef¿ -
cacy of MSC transplantation. This study aimed at (1) assessing the in vitro 
cytocompatibility of this biomaterial, (2) evaluating the in-vivo effect on 
cardiac function after AMI of the intramyocardial injection of this biomate-
rial loaded with MSCs.
The in vitro cytocompatibility was evaluated using cytotoxicity assays, 
measurements of cardiogenic marker gene expression and of contractile cell 
activity. Immediately after coronary artery ligation, 3.106 CFSE-labeled 
MSCs, alone (MSC) or in combination with the biomaterial (MSC+Bm), 
were injected into the myocardium of Lewis congenic rats. Injections of 
the biomaterial alone (Bm) or PBS were also used as controls. Cardiac 
function was assessed using echocardiography at different time-points over 
8 weeks.
Cell viability, expression of cardiogenic markers and synchronous contrac-
tile activity did not differ between cells (cardiomyocytes or MSCs) cultured 
alone or within biomaterial. Left ventricular Ejection Fraction (LVEF) was 
signi¿ cantly reduced from 88.5±0.7% at baseline to 66.3±1.2% at 24h after 
surgery (p<0.001), with no statistical difference between groups. Whereas 
LVEF decreased from D1 to D28 in the PBS group (p<0.001), LVEF signi-
¿ cantly increased in the Bm, MSC, and MSC+Bm groups (p<0.001). 
Interestingly, 7 days after AMI, LVEF was higher in the MSC+Bm group as 
compared to the Bm or MSC groups (p<0.01).
These data showed that intramyocardial injection of a scaffolding biomate-
rial loaded with MSCs induced an early improvement in cardiac function after 
AMI. This study suggests that the injection of MSCs within biomaterial is an 
effective strategy to enhance the effect of cellular transplantation therapy for 
myocardial infarction.
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potential may be important, notably in the management of skin wounds or 
ischemic myocardial injury.
Aim: The aim of our study was to determine whether EPCs can be isolated in 
large number from peripheral blood of healthy or burned patients and expanded 
in vitro. In a second step, we characterized these cells and tested their capacity 
to induce angiogenesis in a mouse model of ischemic limb in vivo.
Mononuclear cells were isolated from peripheral blood samples obtained 
from either healthy donors (100 ml) or severely burned patients (45 ml) and 
cultured in speci¿ c medium. EPC colonies appeared after 2 weeks and could 
be cultured up to 10 passages. They formed tubelike structures on matrigel, 
took up acetylated low-density lipoprotein and bound Ulex lectin. They 
expressed the surface antigens CD34, VEGFR-2, CD31, and E-cadherin, as 
well as the von Willbrand factor and the endothelial isoform of nitric oxide 
synthase (eNOS). After 5 passages of a single clone, cells were generated in 
suf¿ cient number to allow 1-0.5 x106 of them to be injected to nude mice. The 
angiogenic properties of these cells were evaluated in vivo by measuring the 
hindlimb perfusion of nude mice by laser Doppler perfusion image analyses. 
Injection of cells clearly increased the blood À ow recovery in the ischemic 
hindlimb of nude mice. Immunostainings revealed that the injected cells are 
present 1 and 4 weeks after surgery in the nude ischemic legs.
Conclusion: In conclusion, it is possible to isolate endothelial precursor 
cells from a limited amount of peripheral blood from healthy donors or burned 
patients. These cells can be obtained in large number after culture expansion. 
As we evaluated their angiogenic potential in vivo, we suggest that these cells 
could be re-injected in patients in order to treat ischemic damages by cel-
lular therapy. 
2mg/kg, 5 days) and that of a dopaminergic D1 receptor agonist (SKF, i.p. 
2,5mg/kg, 5 days) also enhanced BMC mobilization, recruitment and differen-
tiation and subsequently post-ischemic vessel growth.
These results unravel, for the ¿ rst time, a major role for the sym-
pathetic nervous system in BM-derived cells egress and post-ischemic 
neovascularization.
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In the adult organism, the ability to form new blood vessels via angioge-
nesis or vasculogenesis is essential to wound healing. Endothelial progenitor 
cells (EPCs) have the capacity to differentiate into mature endothelial cells 
and to secrete angiogenic factors in vitro and in vivo. Thus, their therapeutic 
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